Skip to main content
All lobbying filings

FORBES-TATE

Lobbying for HALOZYME THERAPEUTICS, INC. · U.S. Biotechnology Company

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $60,000.00 income · posted Apr 15, 2025

Official filing document

 Lobbying activity 1
Health Issues

Issues related to biopharmaceutical research, development, and manufacturing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem